Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
ASH: Lilly defends survival data blemish in novel BTK trial win
The overall survival analysis created a bit of a problem for Lilly as the hazard ratio edged above 1 in favor of control.
Angus Liu
Dec 9, 2024 5:45pm
Sponsored
A strategic roadmap for your biologics manufacturing
Dec 9, 2024 8:00am
CSL Vifor floats £23M offer to end competition probe in UK
Dec 10, 2024 4:11pm
Sponsored
What’s next in AI’s drug discovery journey
Dec 9, 2024 8:00am
High-flying Eli Lilly plots $15B share buyback campaign
Dec 10, 2024 11:31am
Regulatory tracker: Santhera's Agamree picks up NICE nod
Dec 10, 2024 9:15am
Manufacturing News
EuroAPI taps new CEO from within its ranks
Dec 9, 2024 4:15pm
BioMarin to add €60M lab to Irish manufacturing site
Dec 9, 2024 3:50pm
European officials approve Novo Holdings' planned Catalent buy
Dec 6, 2024 2:48pm
CDMO Resilience cuts 105 jobs at production plant in Florida
Dec 6, 2024 12:12pm
See More Manufacturing News